2021
Panattoni L, Hernandez J, Liu Y , Sacks NC , Higham R, Stephenson B, Armstrong A. Initial treatment patterns for newly diagnosed, commercially insured patients with psoriasis. Poster presentation, ISPOR, April 2021.
Topics: Health Economics and Outcomes Research (HEOR)
Rehorn MR, Sacks N , Cyr PL , Emden, MR, Sherwood R, Pokorney SD. Rates of catheter ablation for paroxysmal supraventricular tachycardia in the United States. J Am Coll Cardiol 77 (18-Sup1):330. Poster Contribution, American College of Cardiology, 2021.
Topics: Epidemiology
Alexander W, Jensen I , Hathway J, Srivastava K, Cyr P, Batt K. Economic IMPACT of utilizing eptacog beta for the on-demand treatment of bleeding events among hemophilia patients with inhibitors. Abstract PBI11 , ISPOR 2021 Annual International Meeting.
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Pang F, Dean R, Jensen I , Olaye A, Miller B. The cost-effectiveness of OTL-200 for the treatment of metachromatic leukodystrophy (MLD) in the US. Abstract PRO30 , ISPOR 2021.
View Abstract
Topics: Health Economics and Outcomes Research (HEOR) , Metachromatic leukodystrophy (MLD)
Sheshadri A, Healey B, Sacks N , Wu E, Cyr P , Boerner G, Huang H. 2021. Bronchiolitis obliterans syndrome following lung transplantation: Economic burden by chronic lung allograft dysfunction (CLAD) stage. J Heart Lung Trans 40(4-Sup):S70; doi: 10.1016/j.healun.2021.01.1913 .
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Niu X, Veeranki S, Dennen S, Liu Y , Shafrin J, Dembek C, Laubmeier K, Williams GR. Hospitalization risk among adults with bipolar I disorder treated with oral atypical antipsychotics: A long-term data analysis of Medicaid claims data. Abstract, CNS Spectrums 26(2):172-173, April 2021; doi: 10.1017/S1092852920002813 .
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
2020
Sacks NC , Healey B, Cyr PL , Batt K, Henig NR. The economic burden of bronchiolitis obliterans syndrome (BOS) in allogenic hematopoietic stem cell transplant (alloHSCT) patients with Medicare coverage. Poster presentation, ISPOR 25th Annual International Meeting, Orlando, FL, May 2020.
Topics: Health Economics and Outcomes Research (HEOR)
Dean R, Arjunji R, Awano H, Igarash A, Tanaka A, Jensen IS , Cyr PL et al. Cost-effectiveness of onasemnogene abeparvocec (ZOLGENSMA) for spinal muscular atrophy type 1 against nusinersen in Japan. ISPOR 25th Annual International Meeting, Orlando FL, 2020.
Topics: Epidemiology , Health Economics and Outcomes Research (HEOR)
Sacks NC , Healey B, Cyr PL , Graham R. Economic burden of X-linked myotubular myopathy (XLMTM) by ventilation status. ISPOR 25th Annual International Meeting, Orlando FL, 2020.
Topics: Epidemiology , Health Economics and Outcomes Research (HEOR)
Miller B, Jensen IS , Dean R, Cyr PL , Slocomb T, James E, Beggs AH. Health resource use in patients with x-linked myotubular myopathy (XLMTM): Data from the RECENSUS Study. ISPOR 25th Annual International Meeting, Orlando FL, 2020.
A Division of